Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

ASPIRE - A GREAT PARTNER
Here are the numbers since our friends at Aspire jumped on board in 2013. These are ballpark from the K.

2013 - 2015 Aspire Agreement
$20 Million in cash for 8.9 million shares of stock
210,500 share commitment fee

2015-2017 Aspire Agreement
$16 Million in cash for 14.7 million shares of stock
160,000 share commitment fee

July 17 - Sept 17 Aspire
$2.1 Million in cash for 2.5 million shares of stock

NEW AGREEMENT SIGNED Sept 2017 - 2020
300,000 share commitment fee

In March 2017 we also had a PIPE
$2.2 mil in cash for 2.5 million shares of stock

TOTALS since 2013

ASPIRE PROVIDED: $38.1 Million in CASH
In exchange: 26.2 Million shares plus 670,500 shares for fees = 26.9 million shares.



Thank you Aspire from taking us from $500K in cash in late 2012 and ZERO human clinical trials to now $4.1 million in cash and 8 HUMAN CLINICAL TRIALS:
Prurisol - Cross over study
Prurisol phase 2 - SUCCESS
Prurisol phase 2b - enrollment complete - data in Dec/Jan
Kevetrin phase 1 - SUCCESS
Kevetrin phase 2a OC - IN-PROGRESS - Interim data Q4
B-ABSSSI phase 2b - SUCCESS - SPA in progress (Compared to Dapto)
B-OM phase 2 - enrollment complete - topline data in NOV/DEC
B-UC/UP phase 2PoC - SUCCESS


All of the above are BILLION DOLLAR possibilities. Stay tuned and thanks again to Aspire for making this possible.